Literature DB >> 12871068

Urokinase receptor and integrin interactions.

Matthias C Kugler1, Ying Wei, Harold A Chapman.   

Abstract

Urokinase receptors (uPAR) were initially thought to function simply as a mechanism to concentrate the urokinase/plasmin system toward the cell surface. However, extensive evidence has accumulated that this glycolipid-anchored receptor also functions in both the adhesive and signaling pathways of many migratory cells. Mechanisms by which uPAR exercises these functions involve complexing with other membrane proteins for signal transduction. One set of functional partners for uPAR on the cell surface are integrins. Recent studies point to important structural features of uPAR:integrin interactions, indicating uPAR to be a cis-acting integrin ligand. In vivo data reveal altered integrin function and cell migration when uPAR:integrin interactions are impaired. Together these observations support the idea that uPAR:integrin interactions may be a focal point of intervention in pathobiology where integrin function is crucial, such as tumor metastasis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12871068     DOI: 10.2174/1381612033454658

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  29 in total

Review 1.  Methods for identifying novel integrin ligands.

Authors:  Denise K Marciano; Sumiko Denda; Louis F Reichardt
Journal:  Methods Enzymol       Date:  2007       Impact factor: 1.600

2.  Extracellular engagement of alpha6 integrin inhibited urokinase-type plasminogen activator-mediated cleavage and delayed human prostate bone metastasis.

Authors:  Michael O Ports; Ray B Nagle; Gerald D Pond; Anne E Cress
Journal:  Cancer Res       Date:  2009-06-02       Impact factor: 12.701

3.  Genetically determined proteolytic cleavage modulates alpha7beta1 integrin function.

Authors:  Jianming Liu; Praveen B Gurpur; Stephen J Kaufman
Journal:  J Biol Chem       Date:  2008-10-21       Impact factor: 5.157

4.  Macrophage-dependent cleavage of the laminin receptor α6β1 in prostate cancer.

Authors:  Isis C Sroka; Cynthia P Sandoval; Harsharon Chopra; Jaime M C Gard; Sangita C Pawar; Anne E Cress
Journal:  Mol Cancer Res       Date:  2011-08-08       Impact factor: 5.852

5.  Intracellular modifiers of integrin alpha 6p production in aggressive prostate and breast cancer cell lines.

Authors:  Apollo D Kacsinta; Cynthia S Rubenstein; Isis C Sroka; Sangita Pawar; Jaime M Gard; Raymond B Nagle; Anne E Cress
Journal:  Biochem Biophys Res Commun       Date:  2014-10-22       Impact factor: 3.575

Review 6.  Integrin Signaling in Cancer: Mechanotransduction, Stemness, Epithelial Plasticity, and Therapeutic Resistance.

Authors:  Jonathan Cooper; Filippo G Giancotti
Journal:  Cancer Cell       Date:  2019-03-18       Impact factor: 31.743

7.  Polymorphonuclear cells stimulate the migration and metastatic potential of rat sarcoma cells.

Authors:  María Mónica Remedi; Ana Carolina Donadio; Gustavo Alberto Chiabrando
Journal:  Int J Exp Pathol       Date:  2009-02       Impact factor: 1.925

Review 8.  VEGF-initiated angiogenesis and the uPA/uPAR system.

Authors:  Johannes M Breuss; Pavel Uhrin
Journal:  Cell Adh Migr       Date:  2012-10-17       Impact factor: 3.405

9.  Calcitonin receptor-stimulated migration of prostate cancer cells is mediated by urokinase receptor-integrin signaling.

Authors:  Shibu Thomas; Maurizio Chiriva-Internati; Girish V Shah
Journal:  Clin Exp Metastasis       Date:  2007-05-09       Impact factor: 5.150

10.  Participation of the urokinase receptor in neutrophil efferocytosis.

Authors:  Young-Jun Park; Gang Liu; Yuko Tsuruta; Emmanuel Lorne; Edward Abraham
Journal:  Blood       Date:  2009-04-27       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.